Genprex collaborators report positive preclinical data on the use of Reqorsa gene therapy at the 2025 AACR Annual Meeting
Both REQORSA alone and in combination with LUMAKRAS demonstrated robust anti-tumor effects in Ras inhibitor resistant non-small cell lung cancer